Healthcare (PRC Firms)
Greater China Region Guide 2024 : China
Band 4
About
Provided by JunHe LLP
JunHe is a leading full-service law firm in China with a proven track record in advising domestic and foreign companies in the life sciences and healthcare sector. With over 30 years of experience, our multidisciplinary team offers expertise in mergers and acquisitions, capital markets, intellectual property, compliance, and dispute resolution. We provide regulatory services for clinical trials and product registrations, IP transaction services, and legal support for corporate finance, compliance, labor, taxation, and dispute resolution. Our unified internal management ensures comprehensive and high-quality services from our cross-sector and cross-regional lawyers.
Recent Major Deals:
- Advised Elpiscience on its Research Collaboration and License Agreement with Astellas
- Advised Grifols in the sale of a 20% equity stake in SRAAS and its strategic alliance with Haier Group and SRAAS
- Advised Usynova in Granting a Global License for KRAS G12D Inhibitors to AstraZeneca
- Assisted Huagai Capital to establish Huagai Medical RMB Fund IV
- Advised Antengene on its Commercialization Partnership with Hansoh Pharma
- Advised ImmuneOnco on its Listing on the HKEx
- Advised Biocytogen on Its Technical Collaboration with Overseas Biopharmaceutical Companies
- Advised Qyuns on its Listing on the Stock Exchange of Hong Kong
Chambers Review
JunHe boasts a dedicated healthcare team acting for key clients in the pharmaceutical, medical devices and financial services sectors. It is capable of advising on licensing and partnership deals, as well as joint venture and investment matters. The firm utilises its strength in capital markets to handle domestic and overseas issuances. Its enviable client roster features Tasly Pharmaceutical Group, China Life Healthcare Fund and Chia Tai Tianqing Pharmaceutical Group.
Tao Xudong is a key client contact.
君合律师事务所拥有一支专注于医疗保健的法律团队，为制药、医疗器械和金融服务领域的关键客户提供服务。该团队能够就许可和合作协议以及合资企业和投资事项提供法律意见。君合能够利用其在资本市场的优势处理国内外的发行项目。其客户名单包括天士力控股集团，国寿大健康基金和正大天晴药业集团。
陶旭东律师是客户的关键联系人。
Work Highlights
- JunHe advised InventisBio on its IPO on the STAR Board of the Shanghai Stock Exchange.
- 君合为益方生物科技对其在上海证券交易所科创板上市提供法律意见。
Strengths
Provided by Chambers
"JunHe are capable of handling complex and sophisticated legal matters. They give timely responses to clients' requests and are able to provide professional and practical solutions for clients."
"They are able to provide cross-disciplinary, comprehensive legal advice and solutions. The team also have strong business awareness."
“君合团队能够处理复杂的法律事务。它能及时响应客户的要求，并能为客户提供专业实用的解决方案。”
“该团队能够提供跨专业的综合性法律意见与解决方案，同时具备很强的商业意识。”
"JunHe are capable of handling complex and sophisticated legal matters. They give timely responses to clients' requests and are able to provide professional and practical solutions for clients."
"They are able to provide cross-disciplinary, comprehensive legal advice and solutions. The team also have strong business awareness."
“君合团队能够处理复杂的法律事务。它能及时响应客户的要求，并能为客户提供专业实用的解决方案。”
“该团队能够提供跨专业的综合性法律意见与解决方案，同时具备很强的商业意识。”
Members
Provided by JunHe LLP
Feng (Frank) ZHOU
Head of Department
Jie TANG
Ke ZHANG
Min ZHAO
Head of Department
